INDA LOGO

Australian production of medical masks to commence from April 2021 with Oerlikon Nonwoven meltblown technology

Australian production of medical masks to commence from April 2021 with Oerlikon Nonwoven meltblown technology

In times of Corona: Online contract signing between Oerlikon Nonwoven and OZ Health Plus for the new order of an Oerlikon Nonwoven meltblown line for Australia.

Neumünster/Germany, Brisbane/Queensland/Australia, July 7, 2020 – Queensland company OZ Health Plus will establish Australia’s first manufacturing plant to make the critical fine plastic material used in most protective face masks. OZ Health Plus has purchased a plant of the Swiss-based technology company Oerlikon to establish a Queensland-based production plant for spun-bond and meltblown nonwovens. These fabrics are essential for Australia’s face mask manufac-turers, who currently produce about 500 million medical and industrial masks per year. However the fabrics have to be imported from overseas and access to these materials has been severely disrupted during the COVID-19 pandemic.

Oerlikon’s German-based business unit Oerlikon Nonwoven has now executed legal and commercial arrangements to supply the specialised machinery which can manufacture the nonwoven material lo-cally. The same machinery is used to make almost all face masks material manufactured in Europe. The world-leading Oerlikon Nonwoven meltblown plant will commence operations in April next year, with a second stage planned for late 2021.

The Oerlikon Nonwoven plant can produce meltblown fabrics for 500 million masks per year, along with other medical and non-medical grade products, filtration products, sanitary items, antiseptic wipes and more. Rainer Straub, Head of Oerlikon Nonwoven said: “We are very proud that we can now for the first time supply our Oerlikon Nonwoven meltblown technology to Australia. Due to the short delivery time, we hope to make our contribution to the Australian population and their safe sup-ply of high-quality protective masks as soon as possible.”

Oerlikon Nonwoven meltblown technology is recognized in the market as the technically most efficient method for producing high-efficiency filter media from synthetic fibers.

Queensland company secures manufacturing plant for the only Australian production of critical face mask material
OZ Health Plus director Darren Fooks said: “Australia has access to raw polypropylene feedstock but lacks the plant to convert that raw material to specialised spunbond and meltblown fabrics. These fabrics are essential for local mask manufacturing. The Australian-based Oerlikon Nonwoven plant will fill the production chain gap for Australia by producing the fabrics we need for mask production and many other products – it will reduce Australia’s protective mask supply chain from thousands of kilo-metres, to tens of kilometres.”

 “Our decision in favor of Oerlikon Nonwoven was a given once we had analyzed the material samples. It was a matter of course for us that the Business Unit of the Oerlikon Manmade Fibers segment could supply high-quality machines and systems”, added Darren Fooks.

OZ Health Plus’ new facilities will take up 15,000 m2 of manufacturing space and will employ 100 full-time roles once the second stage of the project is complete. OZ Health Plus continues to work with both Queensland and Federal Government stakeholders and values their support in bringing this vital capability to Queensland.

Leading meltblown technology
Oerlikon Nonwoven meltblown technology, which can also be used to produce nonwovens for protec-tive masks, is recognized in the market as the technically most efficient method of producing high-separation filter media from plastic fibers. Most of the protective mask capacities available in Europe to date are produced on Oerlikon Nonwoven equipment.

About Oerlikon

Oerlikon (SIX: OERL) develops modern materials, systems and surface technologies and provides specialized services aimed at securing high-performance products and systems with long lifespans for customers. Supported by its technological core competencies and its strong financial footing, the corporation continues its medium-term growth plan by implementing three strategic factors: focusing on attractive growth markets, ensuring structural growth and expanding through targeted M&A activities. Oerlikon is a globally-leading technology and engineering corporation, operating its business in two segments (Surface Solutions and Manmade Fibers) and employing around 11,000 members of staff at 182 sites in 37 countries worldwide. In 2019, Oerlikon generated sales of CHF 2.6 billion and invested more than CHF 120 million in research & development.

For further information: www.oerlikon.com

About the Oerlikon Manmade Fibers segment

With its Oerlikon Barmag, Oerlikon Neumag and Oerlikon Nonwoven brands, the Oerlikon Manmade Fibers segment is one of the leading provider of manmade fiber filament spinning systems, texturing machines, BCF systems, staple fiber systems and solutions for the production of nonwovens and – as a service provider – offers engineering solutions for the entire textile value added chain.

As a future-oriented company, the research and development at this division of the Oerlikon Group is driven by energy-efficiency and sustainable technologies (e-save). With its range of polycondensation and extrusion systems and their key components, the company caters to the entire manufacturing process – from the monomer all the way through to the textured yarn. The product portfolio is rounded off with automation and Industrie 4.0 solutions.

The primary markets for the product portfolio of Oerlikon Barmag are in Asia, especially in China, India and Turkey, and – for those of Oerlikon Neumag and Oerlikon Nonwoven – in the USA, Asia, Turkey and Europe. Worldwide, the segment – with just under 3,000 employees – has a presence in 120 countries with production, sales and distribution and service organizations. At the R&D centers in Remscheid, Neumünster (Germany) and Suzhou (China), highly-qualified engineers, technologists and technicians develop innovative and technologically-leading products for tomorrow’s world.

For further information: www.oerlikon.com/manmade-fibers

About OZ health plus

OZ Health Plus is an Australian-owned, Queensland based company developing vital, sovereign  manufacturing capability for medical grade fabrics. Currently these fabrics are imported from over-seas for processing in Australia creating an unacceptable level of supply chain exposure in a post-COVID world. OZ Health Plus is working to commence Queensland-based manufacturing of these vital supplies early next year using world-leading Oerlikon manufacturing technology.

Contact Information

URL: https://www.oerlikon.com/en/
Company: Oerlikon